chr3-24127685-G-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_001354712.2(THRB):c.958C>A(p.Arg320Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R320L) has been classified as Pathogenic.
Frequency
Consequence
NM_001354712.2 missense
Scores
Clinical Significance
Conservation
Publications
- thyroid hormone resistance, generalized, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- resistance to thyroid hormone due to a mutation in thyroid hormone receptor betaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid hormone resistance, generalized, autosomal recessiveInheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001354712.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| THRB | NM_001354712.2 | MANE Select | c.958C>A | p.Arg320Ser | missense | Exon 10 of 11 | NP_001341641.1 | ||
| THRB | NM_000461.5 | c.958C>A | p.Arg320Ser | missense | Exon 9 of 10 | NP_000452.2 | |||
| THRB | NM_001128176.3 | c.958C>A | p.Arg320Ser | missense | Exon 10 of 11 | NP_001121648.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| THRB | ENST00000646209.2 | MANE Select | c.958C>A | p.Arg320Ser | missense | Exon 10 of 11 | ENSP00000496686.2 | ||
| THRB | ENST00000356447.9 | TSL:1 | c.958C>A | p.Arg320Ser | missense | Exon 10 of 11 | ENSP00000348827.4 | ||
| THRB | ENST00000280696.9 | TSL:5 | c.1003C>A | p.Arg335Ser | missense | Exon 6 of 7 | ENSP00000280696.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: THRB c.958C>A (p.Arg320Ser) results in a non-conservative amino acid change located in the Nuclear hormone receptor, ligand-binding domain (IPR000536) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251466 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.958C>A has been reported in the literature in at-least one individual affected with Thyroid Hormone Resistance, Generalized, Autosomal Dominant (example: Armor_2014). These report(s) do not provide unequivocal conclusions about association of the variant with Thyroid Hormone Resistance, Generalized, Autosomal Dominant. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Multiple different variants affecting the same amino acid residue is reported in association with Thyroid hormone resistance in HGMD and at-least one have been classified pathogenic in ClinVar with multiple entries (CV ID 12557). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
not provided Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at